TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/21/18 16:34 | 5/17/18 | PTGX | Protagonist Therapeutics, Inc | Health | Drug | Pharmaceutical Preparations | Canaan X L.P. | CT | T | S | -237 | 6.09 | 0 | -39 | -2 | 2,117 | D | ||||||||||||||||
5/16/18 17:16 | 5/14/18 | PTGX | Protagonist Therapeutics, Inc | Health | Drug | Pharmaceutical Preparations | Canaan X L.P. | CT | T | S.m | -1,058 | 6.42 | 0 | -165 | -7 | 2,156 | D | ||||||||||||||||
3/26/18 16:25 | 3/23/18 | PTGX | Protagonist Therapeutics, Inc | Health | Drug | Pharmaceutical Preparations | Canaan X L.P. | CT | T | S | -1,241 | 20.71 | 0 | -60 | -3 | 2,320 | D | ||||||||||||||||
3/22/18 17:33 | 3/20/18 | PTGX | Protagonist Therapeutics, Inc | Health | Drug | Pharmaceutical Preparations | Canaan X L.P. | CT | T | S.m | -814 | 20.61 | 0 | -40 | -2 | 2,380 | D | ||||||||||||||||
3/19/18 17:22 | 3/16/18 | PTGX | Protagonist Therapeutics, Inc | Health | Drug | Pharmaceutical Preparations | Canaan X L.P. | CT | T | S.m | -419 | 20.55 | 0 | -20 | -1 | 2,420 | D | ||||||||||||||||
3/15/18 16:55 | 3/13/18 | PTGX | Protagonist Therapeutics, Inc | Health | Drug | Pharmaceutical Preparations | Canaan X L.P. | CT | T | S.m | -272 | 20.66 | 0 | -13 | -1 | 2,440 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |